M. H. Sayegh and L. A. Turka, The role of T-cell costimulatory activation pathways in transplant rejection, N Engl J Med, vol.338, issue.25, pp.1813-1821, 1998.

A. H. Sharpe and G. J. Freeman, The B7-CD28 superfamily, Nat Rev Immunol, vol.2, issue.2, pp.116-126, 2002.

B. J. Nankivell, R. J. Borrows, C. L. Fung, P. J. O'connell, R. D. Allen et al., The natural history of chronic allograft nephropathy, N Engl J Med, vol.349, issue.24, pp.2326-2333, 2003.

F. Vincenti, A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study), Am J Transplant, vol.10, issue.3, pp.535-546, 2010.

A. D. Kirk, Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates, Transplantation, vol.72, issue.3, pp.377-384, 2001.

K. G. Haanstra, Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates, Transplantation, vol.75, issue.5, pp.637-643, 2003.

N. Dilek, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells, PLoS One, vol.28, issue.12, p.83139, 2013.

J. H. Esensten, Y. A. Helou, G. Chopra, A. Weiss, and J. A. Bluestone, CD28 Costimulation: From Mechanism to, Therapy. Immunity, vol.44, issue.5, pp.973-988, 2016.

N. Poirier, Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody, Am J Transplant, vol.12, issue.10, pp.2630-2640, 2012.

R. A. Clark, The vast majority of CLA+ T cells are resident in normal skin, J Immunol, vol.176, issue.7, pp.4431-4439, 2006.

K. Hirahara, L. Liu, R. A. Clark, K. Yamanaka, R. C. Fuhlbrigge et al., The majority of human peripheral blood CD4+C-D25highFoxp3+ regulatory T cells bear functional skin-homing receptors, J Immunol, vol.177, issue.7, pp.4488-4494, 2006.

N. Ali, Xenogeneic graft-versus-host-disease in NOD-scid IL-2R?null mice display a T-effector memory phenotype, PLoS One, vol.7, issue.8, p.44219, 2012.

F. Issa, J. Hester, K. Milward, and K. J. Wood, Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model, PLoS One, vol.7, issue.12, p.53331, 2012.

S. N. Nadig, In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells, Nat Med, vol.16, issue.7, pp.809-813, 2010.

F. Issa, J. Hester, R. Goto, S. N. Nadig, T. E. Goodacre et al., Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model, Transplantation, vol.90, issue.12, pp.1321-1327, 2010.

D. C. Wu, Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model, Transplantation, vol.96, issue.8, pp.707-716, 2013.

A. J. Coyle and J. C. Gutierrez-ramos, The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function, Nat Immunol, vol.2, issue.3, pp.203-209, 2001.

B. Salomon and J. A. Bluestone, Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation, Annu Rev Immunol, vol.19, pp.225-252, 2001.

D. M. Rothstein and M. H. Sayegh, T-cell costimulatory pathways in allograft rejection and tolerance, Immunol Rev, vol.196, pp.85-108, 2003.
DOI : 10.1046/j.1600-065x.2003.00088.x

P. S. Linsley and S. G. Nadler, The clinical utility of inhibiting CD28-mediated costimulation, Immunol Rev, vol.229, issue.1, pp.307-321, 2009.

D. J. Lenschow, Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg, Science, vol.257, issue.5071, pp.789-792, 1992.

L. A. Turka, T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo, Proc Natl Acad Sci, vol.89, issue.22, pp.11102-11105, 1992.

T. C. Pearson, D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry et al., Transplantation tolerance induced by CTLA4-Ig, Transplantation, vol.57, issue.12, pp.1701-1706, 1994.

A. D. Kirk, CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates, Proc Natl Acad Sci USA, vol.94, issue.16, pp.8789-8794, 1997.

M. G. Levisetti, Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation, J Immunol, vol.159, issue.11, pp.5187-5191, 1997.

N. R. Krieger, Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates, J Surg Res, vol.76, issue.2, pp.174-178, 1998.

L. V. Riella, Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model, Am J Transplant, vol.12, issue.4, pp.846-855, 2012.

J. Levitsky, J. Miller, X. Huang, D. Chandrasekaran, L. Chen et al., Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans, Transplantation, vol.96, issue.8, pp.689-696, 2013.

P. S. Linsley, W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle et al., CTLA-4 is a second receptor for the B cell activation antigen B7, J Exp Med, vol.174, issue.3, pp.561-569, 1991.

P. Tan, Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1, J Exp Med, vol.177, issue.1, pp.165-173, 1993.

N. Poirier, FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft, Am J Transplant, vol.15, issue.1, pp.88-100, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02148443

M. Carvalho-gaspar, N. D. Jones, S. Luo, L. Martin, M. O. Brook et al., Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells, J Immunol, vol.180, issue.10, pp.6640-6648, 2008.

D. J. Lenschow, Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse, J Exp Med, vol.181, issue.3, pp.1145-1155, 1995.

C. S. Via, V. Rus, P. Nguyen, P. Linsley, and W. C. Gause, Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD, J Immunol, vol.157, issue.9, pp.4258-4267, 1996.

O. Traitanon, IL-15 induces alloreactive CD28 (-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation, Am J Transplant, vol.14, issue.6, pp.1277-1289, 2014.
DOI : 10.1111/ajt.12719
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083870

R. Zhang, A. Huynh, G. Whitcher, J. Chang, J. S. Maltzman et al., An obligate cell-intrinsic function for CD28 in Tregs, J Clin Invest, vol.123, issue.2, pp.580-593, 2013.

N. Poirier, Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, issue.17, pp.17-27, 2010.

S. Ville, Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection, J Am Soc Nephrol, vol.27, issue.12, pp.3577-3588, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150329

T. Zhang, Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner, Am J Transplant, vol.11, issue.8, pp.1599-1609, 2011.

D. Serres, S. A. Sayegh, M. H. Najafian, and N. , Immunosuppressive drugs and Tregs: a critical evaluation, Clin J Am Soc Nephrol, vol.4, issue.10, pp.1661-1669, 2009.

K. Milward, F. Issa, J. Hester, D. Figueroa-tentori, A. Madrigal et al., Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells, Transplantation, vol.95, issue.1, pp.85-93, 2013.